NCT03644576View on ClinicalTrials.gov

Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

September 12, 2018

Study Completion Date

September 12, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

ozanimod

ozanimod

DRUG

Pseudoephedrine

Pseudoephedrine

DRUG

ozanimod placebo

ozanimod placebo

Trial Locations (1)

78209

ICON Early Phase Services, San Antonio

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY